Related references
Note: Only part of the references are listed.Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles
Nausicaa Clemente et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Nonimmune cell-derived ICOS ligand functions as a renoprotective αvβ3 integrin selective antagonist
Kwi Hye Koh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Expression of ICOSL is associated with decreased survival in invasive breast cancer
Bin Wang et al.
PEERJ (2019)
Integrins as biomechanical sensors of the microenvironment
Jenny Z. Kechagia et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Cross-linking mass spectrometry: methods and applications in structural, molecular and systems biology
Francis J. O'Reilly et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Luigi Mario Castello et al.
MEDIATORS OF INFLAMMATION (2017)
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis
Chiara Dianzani et al.
SCIENTIFIC REPORTS (2017)
Osteopontin -- a promising biomarker for cancer therapy
Ran Wei et al.
JOURNAL OF CANCER (2017)
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo
Casimiro L. Gigliotti et al.
JOURNAL OF IMMUNOLOGY (2016)
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo
Elena Boggio et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
Nausicaa Clemente et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Osteopontin Shapes Immunosuppression in the Metastatic Niche
Sabina Sangaletti et al.
CANCER RESEARCH (2014)
Pattern Recognition Receptor Signaling in Human Dendritic Cells is Enhanced by ICOS Ligand and Modulated by the Crohn's Disease ICOSLG Risk Allele
Matija Hedl et al.
IMMUNITY (2014)
B7h Triggering Inhibits the Migration of Tumor Cell Lines
Chiara Dianzani et al.
JOURNAL OF IMMUNOLOGY (2014)
Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression
Lora C. Bailey-Downs et al.
PLOS ONE (2014)
Advantages of proteins being disordered
Zhirong Liu et al.
PROTEIN SCIENCE (2014)
Cooperative Unfolding of Compact Conformations of the Intrinsically Disordered Protein Osteopontin
Dennis Kurzbach et al.
BIOCHEMISTRY (2013)
Triggering of B7h by the ICOS Modulates Maturation and Migration of Monocyte-Derived Dendritic Cells
Sergio Occhipinti et al.
JOURNAL OF IMMUNOLOGY (2013)
Pre- and post-translational regulation of osteopontin in cancer
Pieter H. Anborgh et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2011)
B7h Triggering Inhibits Umbilical Vascular Endothelial Cell Adhesiveness to Tumor Cell Lines and Polymorphonuclear Cells
Chiara Dianzani et al.
JOURNAL OF IMMUNOLOGY (2010)
Signal co-operation between integrins and other receptor systems
Charles H. Streuli et al.
BIOCHEMICAL JOURNAL (2009)
Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells
Gusheng Tang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma
V. Takafuji et al.
ONCOGENE (2007)
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency
K Warnatz et al.
BLOOD (2006)
Inducible co-stimulator null MRL-Fas(lpr) mice: Uncoupling of autoantibodies and T cell responses in lupus
Geraldine C. Zeller et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion
Lingegowda S. Mangala et al.
MOLECULAR CANCER (2005)
A novel zinc finger transcriptional repressor, ZNF224, interacts with the negative regulatory element (AldA-NRE) and inhibits gene expression
L Medugno et al.
FEBS LETTERS (2003)
Share Paper
